Ligandal utilizes artificial intelligence for precision targeting and delivery in therapeutics. The company offers AI-driven peptide design and a database of custom-designed targeting molecules.

Ligandal

Ligandal | 1,208 followers on LinkedIn. Ligandal is developing precision molecular therapeutics and targeted delivery technologies. | Ligandal is a genetic medicine company that uses nanotechnology to develop targeted and personalised therapies. As a regenerative medicine biotechnology company, Ligandal develops ultra-rapid therapeutics and vaccines for outbreaks and pandemics, in addition to its work in immuno-oncology and rare genetic diseases. Our current focus is on delivering a peptide-based cure to the COVID-19 pandemic (SARS-CoV-2 coronavirus), as part of a broader mission of enabling personalized medicine on a global scale through the power of nanomedicine and gene therapies.

Author, speaker, connector

Christine Peterson

Mark Young

Chief Innovation Officer @ Sama Therapeutics | AI & Data Science Advisor

Russell Hanson

Chairman & CEO @Ligandal, Biomaterials Scientist and Nanoengineer, Forbes 30Under30 in Healthcare

Andre Watson

Ligandal ’s CEO, Andre Watson, presented at the second annual Entrepreneurship, Longevity and Biotech conference at Florida Atlantic University - College of Business

LIGA

COM:LIGANDAL

Ligandal

locale

market

industry

website

linkedin

peer of

Metrics